ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|CNS Disease
Interventions: DRUG: ZK219477
Sponsor: Nancy Lin, MD
Collaborators: Brigham and Women's Hospital|Bayer|Breast Cancer Research Foundation